Previous Article | Next Article 
Journal of Virology, August 2001, p. 7420-7428, Vol. 75, No. 16
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.16.7420-7428.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
High Numbers of Viral RNA Copies in the Central Nervous
System of Mice during Persistent Infection with Theiler's
Virus
Mark
Trottier,1,2
Pat
Kallio,1
Wei
Wang,1,3 and
Howard
L.
Lipton1,2,4,5,*
Department of Neurology, Evanston
Hospital,1 and Departments of
Neurology,5
Microbiology-Immunology,4 and
Biochemistry, Molecular Biology and Cell
Biology,2 and Neuroscience Graduate
Program,3 Northwestern University, Evanston,
Illinois
Received 16 January 2001/Accepted 16 May 2001
 |
ABSTRACT |
The low-neurovirulence Theiler's murine encephalomyelitis viruses
(TMEV), such as BeAn virus, cause a persistent infection of the central
nervous system (CNS) in susceptible mouse strains that results in
inflammatory demyelination. The ability of TMEV to persist in the mouse
CNS has traditionally been demonstrated by recovering infectious virus
from the spinal cord. Results of infectivity assays led to the notion
that TMEV persists at low levels. In the present study, we analyzed the
copy number of TMEV genomes, plus- to minus-strand ratios, and
full-length species in the spinal cords of infected mice and infected
tissue culture cells by using Northern hybridization. Considering the
low levels of infectious virus in the spinal cord, a surprisingly large
number of viral genomes (mean of 3.0 × 109) was
detected in persistently infected mice. In the transition from the
acute (approximately postinfection [p.i.] day 7) to the persistent
(beginning on p.i. day 28) phase of infection, viral RNA copy numbers
steadily increased, indicating that TMEV persistence involves active
viral RNA replication. Further, BeAn viral genomes were full-length in
size; i.e., no subgenomic species were detected and the ratio of BeAn
virus plus- to minus-strand RNA indicated that viral RNA replication is
unperturbed in the mouse spinal cord. Analysis of cultured macrophages
and oligodendrocytes suggests that either of these cell types can
potentially synthesize high numbers of viral RNA copies if infected in
the spinal cord and therefore account for the heavy viral load.
A scheme is presented for the direct isolation of both cell types
directly from infected spinal cords for further viral analyses.
 |
INTRODUCTION |
Theiler's murine
encephalomyelitis virus (TMEV), an enteric pathogen of mice
containing a single-stranded RNA genome of positive polarity, belongs
to the Picornaviridae family (31). TMEVs can be
divided into two groups based on neurovirulence following intracerebral (i.c.) inoculation of mice. High-neurovirulence strains, such as GDVII,
produce a rapidly fatal encephalitis in mice. Low-neurovirulence TMEVs,
such as BeAn and DA, cause a persistent infection of the central
nervous system (CNS) in susceptible mouse strains that results in
immune-mediated damage, as well as viral destruction of
oligodendrocytes and, hence, demyelination (2, 9, 13, 36).
After i.c. inoculation of mice, the low-neurovirulence strains infect
neurons in the gray matter of the brain and spinal cord during the
acute phase of virus growth, which is followed by virus persistence in
cells in the spinal cord white matter. During the persistent phase of
infection, TMEV RNA and antigens have been found mainly in macrophages
(24, 30) and to a lesser extent in oligodendrocytes and
astrocytes (1). In contrast to the experience of other
investigators, we have not detected virus antigen in astrocytes of SJL
mice injected with 106 PFU of BeAn virus, which
produces an onset of demyelinating disease more rapid than that
observed after infection of these mice with DA virus (24,
34).
The ability of TMEV to persist in the mouse CNS has traditionally been
demonstrated by recovering infectious virus from the spinal cord.
Results of infectivity assays led to the notion that TMEV persists at
low levels, usually with <104 PFU detected per
spinal cord (6, 23). Northern hybridization to detect TMEV
RNA has proven to be a sensitive method of analyzing TMEV persistence
(3) and the relative abundance of TMEV RNA in spinal cords
from infected mice (21).
In the present study, we analyzed the copy number of TMEV genomes,
plus- to minus-strand ratios, and full-length species in the spinal
cords of infected mice and infected tissue culture cells by using
Northern hybridization. Considering the low levels of infectious virus
in the spinal cord, a surprisingly large number of viral genomes was
detected in persistently infected mice, even as late as postinfection
(p.i.) day 223. The temporal graph of viral RNA copies in the acute
phase versus the persistent phase of infection indicated that TMEV
persistence involves active viral RNA replication. Analysis of cultured
macrophages and oligodendrocytes suggests that either of these cell
types can potentially synthesize high numbers of viral RNA copies if
infected in the spinal cord and therefore account for the heavy
viral load. A scheme is presented for the direct isolation of both cell
types directly from infected spinal cords for further viral analyses.
 |
MATERIALS AND METHODS |
Cells.
BHK-21 cells were maintained in Dulbecco's modified
Eagle medium supplemented with 2 mM L-glutamine, 100 µg
of streptomycin per ml, 100 U of penicillin per ml, 7.5% fetal bovine
serum (FBS), and 6.5 mg of tryptose phosphate broth (Gibco/BRL) per ml
at 37°C in a 5% CO2 atmosphere. Viral plaques
were assayed on BHK-21 cell monolayers in 35-mm-diameter
multiwell plates by staining with crystal violet after incubation for 4 days at 33°C in a 5% CO2 atmosphere as
previously described (37). N20 mature mouse
oligodendrocytes (obtained from Anthony Campagnoni) (12)
were grown in Dulbecco's modified Eagle medium-F12 medium containing
100 µg of streptomycin per ml, 100 U of penicillin per ml, and 10%
FBS at 37°C in a 5% CO2 atmosphere. M1-D cells
were derived from the myelomonocytic cell line M1 by treatment with
conditioned medium and maintained as previously described
(20).
Mice and virus inoculations.
SJL (female), CBA, and C.B-17
mice, purchased from The Jackson Laboratory (Bar Harbor, Maine), were
caged and maintained in accordance with American Association for
Accreditation of Laboratory Animal Care standards and received
autoclaved standard mouse chow and water ad libitum. Mice (6 to 8 weeks
old) were anesthetized with 1 mg of pentobarbital intraperitoneally and
inoculated in the right cerebral hemisphere with
106 PFU of virus.
Virus infections.
Nearly confluent BHK-21, N20, and M1-D
cell monolayers in 100-mm-diameter dishes were washed with
phosphate-buffered saline (PBS; pH 7.4) and infected with BeAn virus at
a multiplicity of 10. Following 45 min of incubation at 24°C to allow
virus attachment, cell monolayers were washed twice with PBS, infection
medium (same as the growth medium used for each cell type, except that
the FBS concentration was reduced to 0.5%) was added, and incubation was continued at 37°C in a 5% CO2 atmosphere.
Isolation of CNS cells from spinal cords.
Spinal cords
flushed from the spinal canals of mice with chilled PBS deficient in
Ca2+ and Mg2+ were
dissected into 1-mm pieces and dissociated into a single-cell suspension by incubation in 300 U of RNase-free type III collagenase (Worthington Biochemical Corp., Lakewood, N.J.) per ml in Hanks balanced salt solution for 15 min at 37°C. Collagenase digestion was
repeated several times or until tissue fragments no longer remained.
Cell suspensions were then sieved through screens (Sefar American Inc.,
Kansas City, Kans.) of graded pore sizes (350, 209, 130, and 38 µm for oligodendrocytes and 350, 209, and 130 µm for macrophages).
Passage though the 38-µm-pore-size screen ensured dissociation of
oligodendrocytes from myelin and elimination of most macrophages.
Oligodendrocytes were isolated by centrifugation through 0.9 M sucrose
in 35-ml Oakridge tubes (40), followed by incubation of
the resuspended cells on plastic petri dishes for 20 min at 37°C to
remove any remaining macrophages. Greater than 90% of these cells
stained with mouse monoclonal antibody (MAb) 8-18C5 to myelin
oligodendrocyte glycoprotein (MOG). Macrophages were isolated on
discontinuous Percoll gradients in 30-ml Oakridge tubes, harvested from
the band at the 30 to 70% Percoll interface, and phenotyped by flow
cytometry as previously described (10). This band
contained, on average, 25% macrophages (MOMA-2 or Mac-1 positive) and
75% B and T lymphocytes; since B and T lymphocytes are not infected by
TMEV, these cells could be assayed directly or macrophages could be
obtained by panning for viral genome analyses.
Total-RNA isolation.
For cell cultures, Trizol solution
(Gibco) was added directly to infected or uninfected monolayers
in 100-mm-diameter dishes, whereas tissues (brains and
spinal cords) were frozen in liquid nitrogen, broken into pieces, and
placed in 13 and 1 ml of Trizol, respectively. Cells or pieces of
tissue were homogenized with a Polytron (Beckman Instruments), and
total RNA was isolated by following the manufacturer's
recommendations. The quality and amount of RNA in spinal cord samples
from individual mice were ascertained by examining 18S and 28S rRNAs by
agarose gel electrophoresis.
Northern hybridization.
Total RNA from mouse tissues or cell
cultures was ethanol precipitated, resuspended in RNA loading buffer
[50% formamide, 7% formaldehyde, 0.04% bromophenol blue in 200 mM
3-(N-morpholino)propanesulfonic acid (pH 7.0), 50 mM sodium
acetate, 10 mM EDTA (MOPS buffer)], heated for 5 min at 95°C, and
electrophoresed in a 1% agarose gel at 80 to 90 V for 1 h. The
gel was soaked in distilled water for 15 min and in 5× SSC (20× SSC
is 3 M NaCl plus 0.3 M Na citrate) with 10 mM NaOH for 30 min. RNA was
passively transferred to a Bright-star plus nylon membrane (Ambion
Inc.), treated with short-wavelength UV light for 2 min, and
prehybridized with Ultra-hyb solution (Ambion) for at least 30 min at
42°C. A random-primed DNA probe specific for BeAn virus was derived
from a 1.5-kb EcoRI fragment of BeAn cDNA spanning
nucleotides 2772 to 4295 by using the Random Primed DNA Labeling Kit
(Boehringer Mannheim) with a specific activity of at least
109 cpm/µg. The probe was added to the
prehybridization solution, and hybridization was carried out overnight
at 42°C. Membranes were washed once with 1× SSC-0.1% sodium
dodecyl sulfate at 24°C for 20 min and three times with 0.2×
SSC-0.1% sodium dodecyl sulfate at 68°C for 20 min each time,
dried, and exposed to a Molecular Dynamics PhosphorImager screen to
detect BeAn virus with the
[
-32P]dCTP-labeled hybridized probe.
For dot blots, RNA was serially diluted and 10 µl was mixed with 20 µl of formamide, 7 µl of formaldehyde, and 2 µl of 20× SSC and
samples were heated for 15 min at 68°C. Two volumes of 20× SSC was
added, and samples were loaded onto a Minifold dot blot apparatus
(Schleicher & Schuell) containing a nitrocellulose filter presoaked in
20× SSC for 1 h and washed with 10× SSC. Samples were vacuum
drawn through the dot blot apparatus, and the filter was washed twice
with 0.5 ml of 10× SSC, dried for 2 h at 80°C under vacuum,
prehybridized, hybridized, and washed as described above.
Detection of minus-strand TMEV RNA.
A modified RNase
protection method using reagents from the RPA III kit (Ambion) and
Northern blots were used to detect double-stranded RNA (dsRNA)
(29). Briefly, total RNA from infected cells (in cell
cultures or in tissue) was heated to 95°C for 5 min and incubated overnight at 42°C to anneal plus- and minus-strand viral RNA. Annealed RNA was treated with a 1:100 dilution of RNases A and T1 (RPA
III kit; Ambion) for 30 min at 37°C. The reaction was terminated with
RNase inactivation-precipitation buffer and kept at
20°C to
precipitate RNA. Resuspended dsRNA was blotted onto nitrocellulose
filters and probed with
-32P-labeled BeAn DNA
as described above. The signal in RNase-treated samples corresponds
only to dsRNA, since RNase treatment digested excess plus strands that
did not anneal to minus strands. The ratio of plus to minus strands was
determined by parallel dot blots of RNase-treated and untreated RNAs,
with 50% of the signal detected in RNase-treated samples representing
the copy number of minus strands. Treatment of BeAn RNA from purified
virions with RNase was used in experiments to control for the
completeness of RNase digestion.
Flow cytometry.
For each experiment with cells from
gradients, 0.1 × 106 to 0.5 × 106 cells were washed once in cold PBS (pH 7.2)
containing 2.0% bovine serum albumin and 0.02% sodium azide, blocked
by incubation with 10 µl of normal goat and human sera and Fc block
(Pharmingen), and stained for surface antigens (CD3, CD19, Mac-1, and
MOG) or treated with 0.3% saponin to permeabilize cell membranes for
cytoplasmic staining (MOMA-2) as previously described
(19).
Reagents and antibodies.
The following antibodies and
reagents were used: 7-aminoactinomycin D (7-AAD; DNA staining; Sigma),
biotinylated mouse MAb 8-18C5 (anti-MOG; Minnetta Gardinier, Iowa City,
Iowa), CD3-fluorescein isothiocyanate (FITC) (T lymphocytes),
CD19-phycoerythrin (B lymphocytes; Pharmingen), cow glial fibrillary
acidic protein (astrocytes; DAKO), rat MAbs MOMA-2 and Mac-1
(macrophages; G. Kraal, Amsterdam, The Netherlands, and Caltag,
respectively), and goat anti-rat immunoglobulin G-FITC (mouse absorbed; Caltag).
 |
RESULTS |
Determination of viral genome copy numbers in infected tissues and
cells.
Total RNA from BeAn virus-infected mouse spinal cords was
analyzed for BeAn viral genomes by using a Northern hybridization assay. RNA from infected tissues was blotted onto nitrocellulose filters along with known amounts of in vitro-transcribed BeAn viral RNA
diluted in uninfected brain total RNA to generate a standard curve for
the quantitation of viral RNA copies (Fig. 1A and B). Filters were scanned with a
Molecular Dynamics PhosphorImager before quantification. The detection
limit for BeAn viral RNA by Northern hybridization was approximately 32 pg of RNA or 9 × 106 viral genomes (Fig. 1A
and B).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 1.
Method for quantitation of BeAn genomes in individual
mouse spinal cords. Total RNA was extracted from spinal cords, blotted
onto nitrocellulose filters, probed with an
[ -32P]dCTP-labeled BeAn virus sequence, and quantified
by phosphorimaging. (A) Northern dot blot of serial fivefold dilutions
of a standard in vitro-transcribed BeAn virus RNA and representative
spinal cord total RNAs from infected mice killed on the indicated days
p.i. (B) Standard curve derived from Northern hybridization of known
amounts of in vitro-transcribed BeAn virus RNA shown in panel A. The
sensitivity of this technique was 9 × 106 viral
genomes.
|
|
The amount of total RNA extracted from the spinal cords of infected
mice varied, depending on the age or size of the mouse. To normalize
the number of BeAn viral genomes in a mouse spinal cord based on the
number of genomes per microgram of total RNA, the mean amount of total
RNA per spinal cord ± the standard deviation (SD) (51.90 ± 34.82 µg; n = 48) was used because, on occasion, the
spinal cord was not completely extracted from the spinal canal. For
example, if 1 ng or 3 × 108 genomes of BeAn
was detected in 10 µg of total RNA applied to filters in a Northern
blot assay, the number of viral genomes per spinal cord was calculated
as (3 × 108) × 51.9 µg/10 µg, or
1.56 × 109.
High levels of BeAn RNA copies detected in the spinal cords of
persistently infected SJL mice.
Northern hybridization revealed
BeAn viral genomes in 64% (9 of 14) of the spinal cords of mice during
the acute phase of infection (before p.i. day 21) and in 88% (30 of
34) of the samples during the persistent phase of infection (after p.i.
day 28) (Fig. 2). The number of RNA
copies increased until p.i. days 35 to 50, reaching a plateau between
p.i. days 50 and 125 and slowly declining thereafter. These results
demonstrate that the mean number (± the standard error) of viral
genomes per cord during persistence (p.i. days 28 to 223) was
(3.01 ± 0.55) × 109
(n = 30), a surprisingly large number of viral genomes
during this phase.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 2.
(Top) Temporal detection of BeAn virus RNA copies in the
spinal cords of infected mice using an
[ -32P]dCTP-labeled BeAn sequence as a probe for
Northern hybridization (left ordinate). The use of similar amounts of
RNA in specimens was judged from 18S and 28S rRNAs following agarose
gel electrophoresis. There was a rise in the number of viral RNA copies
between p.i. days 7 and 28, as shown (the dashed line between p.i. days
0 and 7 is simulated), suggesting that active RNA viral replication is
required for viral persistence, in contrast with viral infectivity
(shown below). Samples with virus copy numbers below the level of
detection (9 × 106 viral genomes) are not shown (two
samples on day 7, three on day 21, two on day 29, one on day 36, and
one on day 70). (Bottom) Temporal profile of viral infectivity (number
of PFU per cord) of clarified spinal cord homogenates showing a
decline in virus titers after p.i. day 14 (right ordinate).
|
|
In contrast, infectious virus remained in the range of
102 to 104 PFU per spinal
cord between p.i. days 28 and 125 (Fig. 2). The ratio of viral genomes
to PFU was on the order of 106:1 to
107:1 during the persistent infection phase,
compared to a ratio of 103:1 during the acute
infection phase, suggesting a restriction in the production of
infectious virus after p.i. day 28 and/or neutralization of infectious
virus by virus-specific antibodies or cellular immune responses (see below).
Size of BeAn viral genomes in the spinal cord.
Northern
hybridization to determine whether BeAn viral genomes were altered in
size during the persistent phase of infection in mice revealed
full-length genomes on p.i. days 46 and 70 (Fig. 3). Similar results were obtained on p.i.
days 127 and 147 (data not shown). No subgenomic species were detected
during the persistence phase.

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 3.
Detection of full-length BeAn virus RNA genomes during
persistent infection of mice. Total RNA was prepared from infected
cells in culture or from mouse spinal cords. RNA was electrophoresed on
a denaturing agarose gel, transferred to nylon filters, and probed with
an [ -32P]dCTP-labeled BeAn virus sequence. A, 100 ng
of in vitro-transcribed BeAn RNA; B, 1 µg of uninfected BHK-21 cell
total RNA; C, 1 µg of BeAn virus-infected BHK-21 cell total RNA; D, 1 µg of uninfected N20 cell total RNA; E, 1 µg of BeAn virus-infected
N20 cell total RNA; F, 1 µg of BeAn virus-infected M1-D cell total
RNA; G, 10 µg of spinal cord total RNA at p.i. day 46; H, 10 µg of
spinal cord total RNA at p.i. day 70. The arrow indicates full-length
BeAn RNA.
|
|
BeAn RNA copies in brains and spinal cords of CBA and C.B-17
scid mice.
Spinal cords of CBA mice persistently
infected with BeAn show more severe pathological changes than do those
of SJL mice, and crystalline arrays of virions have been detected in
CBA mouse oligodendrocytes (2). These observations are
indicative of a cytolytic infection of oligodendrocytes, where larger
numbers of viral RNA copies are expected. BeAn infection of C.B-17
scid mice, lacking humoral and cellular immune viral
clearance mechanisms (28), would also be expected to
produce larger numbers of viral genomes than in SJL mice. Northern
hybridization analysis of 8 CBA and 10 C.B-17 scid mice
inoculated i.c. with virus (all of the CBA mice but only 6 of the
C.B-17 mice survived for more than 21 days p.i.) revealed viral genome
loads in their spinal cords (Table 1)
similar to those in the spinal cords of SJL mice (Fig. 2). However,
C.B-17 scid mice had on the order of
1011 RNA copies in the brain, in contrast to the
<107 RNA copies found in those of SJL mice at a
comparable time (Table 1). These results not only point to the
persistence of TMEV primarily in the spinal cord but show that in an
immunodeficient host, virus replication also takes place in the brain
during the persistent phase of infection.
BeAn viral genome loads in oligodendrocytes and macrophages in
culture.
Immunohistochemical and in situ hybridization analyses of
spinal cords from mice persistently infected with TMEV indicate that
the majority of infected cells in the spinal cord are macrophages, although oligodendrocytes and astrocytes may also be infected (1,
24). To provide information on the viral genome loads in
specific infected cells in the mouse CNS, we measured the viral genome
loads in a murine myelomonocytic cell line (M1) differentiated into
macrophages (M1-D) (20) and a mature murine
oligodendrocyte cell line, N20 (12); astrocytes were not
tested because few have been detected in demyelinating lesions in BeAn
virus-infected SJL mice and none of those were infected (24,
33). Cells were infected with BeAn virus at a high multiplicity,
and viral RNA copies synthesized at 8 h p.i., i.e., the peak of
viral RNA replication (data not shown), were analyzed by Northern
hybridization and infectious virus was measured by standard plaque
assay (Table 2). Lytic BeAn virus
infection of BHK-21 cells, used as a control cell population, has been
demonstrated (19). Each infected M1-D cell synthesized
approximately 3 × 105 viral genomes, an
amount similar to that in BHK-21 cells; however, the production of
infectious virus was markedly reduced (5 PFU per M1-D cell, compared to
350 PFU per BHK-21 cell). In N20 cells, the number of viral RNA genomes
and the level of infectious virus were similar to those in BHK-21
cells. Only full-length viral genomes were detected in these cell lines
(Fig. 3). Thus, while both macrophages and oligodendrocytes can produce
large numbers of TMEV genomes, infection in macrophages is restricted,
with a block after viral RNA replication.
Viral genome loads in oligodendrocytes and macrophages isolated
from infected spinal cords.
The viral genome loads in specific
cell types were analyzed by using spinal cords from four to eight
infected mice sacrificed at each time point between p.i. days 60 and
120, when mononuclear infiltration and demyelination of white matter
are extensive (M. Felrice, P. Kallio, R. Ramesh, and H. L. Lipton,
submitted for publication). Single-cell suspensions were
generated from the cords by collagenase treatment. The mean numbers of
genomes in the whole spinal cord (3.0 × 109) (Fig. 4A) and
in single-cell suspensions (2.8 × 109)
(Fig. 4B) were similar, indicating that cells could be dissociated from
the spinal cord without loss of viral RNA copies.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 4.
Method used to isolate oligodendrocytes and macrophages
from spinal cords of persistently infected SJL mice. The viral RNA copy
number determined by Northern hybridization is indicated at each step.
(A) During the persistent phase of infection, the mean number (± SD)
of viral genomes in whole spinal cords was 3.0 × 109 ± 0.6 × 109
(n = 30; data from Fig. 2). (B) The mean number (± SD) of viral genomes in single-cell suspensions after collagenase
treatment of minced spinal cords, including cells in efflux from
PBS-forced flushing of spinal canals, was 2.8 × 109 ± 2.4 × 109
(n = 3). (C) Representative experiment for
isolation of oligodendrocytes by centrifugation through 0.9 M sucrose
(most of the macrophages were eliminated from this gradient by passage
of cells through a 38-µm screen). (D) Isolation of macrophages in
Percoll gradients at the 30 to 70% interface (since only
larger-pore-size screens were used to dissociate the cells, all of the
cell types were present in this gradient). (E) Distribution of the
viral genome load based on the combined data in panels C and D, i.e.,
18% in oligodendrocytes (Oligos; 4.2 × 108/2.38 × 109), 8% in macrophages (Macs; 2.0 × 108/2.38 × 109), and 74% in the myelin
fraction at the top of Percoll gradient (2.1 × 109/2.38 × 109 to 4.2 × 108/2.38 × 109). RBCs, red blood cells;
assoc., associated.
|
|
Single-cell suspensions were then used to isolate either
oligodendrocytes or macrophages by centrifugation through a sucrose or
Percoll gradient, respectively; no similar method exists for direct
isolation of astrocytes without incubation in vitro for 1 to 2 weeks at
37°C and the use of neonatal rather than adult rodents
(35). Oligodendrocytes were isolated by passing the single-cell suspension through screens of graded sizes (250 to 38 µm), followed by pelleting through 0.9 M sucrose (Fig. 4C) and then
panning on plastic to eliminate any remaining macrophages. Passage
through the 38-µm-diameter screen not only dissociated oligodendrocytes from myelin membranes but also eliminated most macrophages (40). Two-thirds of the viral genomes were in
the cell pellet rather than in the myelin layer after centrifugation of
oligodendrocytes through 0.9 M sucrose. This number is equivalent to
18% of the total viral genome load in the experiment whose results are
shown (Fig. 4E, legend).
Macrophages were isolated by passing the single-cell suspension through
graded-size screens (250 to 130 µm) (Fig. 4D) and centrifugation
through a discontinuous Percoll gradient, which left oligodendrocytes
in the macrophage gradients (Fig. 4D). The majority (74%) of the viral
genome load was found in the myelin fraction at the top of the
gradient, while only 8% of viral genomes were found in the macrophage
fraction at the 30 to 70% Percoll interface (Fig. 4E, legend). Table
3 gives the viral genome loads found in
additional isolation experiments.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Abundance of BeAn viral genomes in oligodendrocytes and
macrophages isolated from spinal cords of infected SJL mice
|
|
Since the majority of the viral load in the Percoll gradient was in the
myelin debris, we analyzed the myelin debris by flow cytometry. As
shown in Fig 5A and B, we were able to
distinguish between myelin profiles and nucleated cells by using 7-ADD,
a DNA stain, which revealed a number of cells in the myelin layer at
the top of the Percoll gradient (1.97 × 106) equivalent to that in the macrophage
fraction in Fig. 4D (1.60 × 106). Flow
cytometry showed that one-fourth of the 7-ADD-stained cells in the
myelin layer were macrophages, a number equivalent to that in the
macrophage fraction (Fig. 5C and D), while only a small percentage were
oligodendrocytes (data not shown). Therefore, an additional 8% of the
viral genome load may have been present in macrophages trapped in the
myelin debris. However, two-thirds of the cells from the single-cell
suspensions were consistently lost on gradients (data not shown).
Therefore, a large portion of the viral genome load in the myelin layer
probably represents viral RNA released from lysed cells and adhering to
myelin or sedimenting at the top of the gradient.

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 5.
Flow cytometric analysis of cells in the myelin fraction
at the top of the Percoll gradient in Fig. 4D. (A) Combined
fluorescence and light photomicrograph of an aliquot of the myelin
fraction allowed to settle onto a slide. Three nucleated cells stained
with 7-AAD (anti-DNA) are shown amid many unstained myelin profiles.
Aggregation of myelin profiles is, in part, due to settling and
superimposition of some profiles. Magnification, ×400. (B) Forward-
and side-scatter characteristics of the two components (cells and
myelin profiles) in the myelin fraction indicative of size and
granularity. (C) Forward- and side-scatter characteristics of
7-AAD-gated cells. Not shown is separation of the two components on the
7-AAD forward-scatter dot plot that enabled nucleated cells to be
gated. (D) Dot plot of 7-AAD-gated cells in panel C stained with MOMA-2
(cytoplasmic staining) and goat anti-rat immunoglobulin G-FITC.
Quadrants are set on cells stained only with the secondary antibody.
|
|
Ratio of plus- to minus-strand viral RNA in infected spinal
cords.
Picornaviruses synthesize 30 to 70 plus strands for each
minus strand, a ratio that can serve as a measure of picornavirus RNA
replication in an acute cytolytic infection (14, 29). The
ratio of BeAn virus plus- to minus-strand RNA was in the range of 35:1
to 38:1 in BHK-21 cells, murine oligodendrocytes (N20), and
differentiated macrophages (M1-D) (Table
4). Similar ratios were found in the
spinal cords of persistently infected SJL mice. Thus, plus-strand viral
RNA replication appears to be unperturbed in the mouse spinal cord and,
taken together with the high viral genome load, this suggests that
viral RNA replication is most likely normal in oligodendrocytes and
macrophages in the spinal cord.
 |
DISCUSSION |
A heavy BeAn viral genome load but low levels of infectivity in the
spinal cord during persistence.
Historically, TMEV persistence in
susceptible mice has been determined by the recovery of infectious
virus from spinal cords. Results of infectivity assays have led to the
belief that TMEV persists at only low levels in the CNS and that
infection is highly restricted at one or more steps in the viral life
cycle. Northern hybridization analysis of viral genomes in total RNA
extracted from spinal cords has provided a semiquantitative method that allows comparison of the amounts of TMEV RNA in different animals (3, 21). However, a linkage between detection of TMEV RNA and the total genome load has never been made. In this study, we used
Northern hybridization to quantify viral genomes in TMEV-infected mouse
spinal cords, the principal site of viral persistence. Between 108 and 1010 viral RNA
copies were present in spinal cords of infected mice (mean, 3 × 109 genomes per spinal cord), even as late as
p.i. day 223 (Fig. 2). These genome levels were unexpected but not
without precedent. In persistent infections of other RNA viruses, e.g.,
human immunodeficiency virus type 1 (HIV-1) in humans
(32), simian immunodeficiency virus in macaques (17,
41), chimeric simian-human immunodeficiency virus in macaques
(15), and hepatitis C virus (HCV) in humans (38,
43), levels between 106 and
108 viral RNA copies per ml of plasma have been
demonstrated. In fact, virus turnover rates in HIV-1 and HCV infections
are remarkably similar and have been calculated to be on the order of
1010 virions per day (18, 42, 43).
Half-life data acquired based on the use of antiviral inhibitors
suggest that HIV-1 and HCV replicate continuously in vivo; analogous
studies should help to determine whether this is also the case for TMEV
persistence in mice.
In contrast to the heavy viral genome load found during TMEV
persistence, levels of
104 PFU per cord have
been detected by most investigators (for example, see references
6 and 23). Thus, the ratio of viral RNA copies to PFU
during persistence is on the order of 106:1, or 3 orders of magnitude higher than that observed in acutely infected
spinal cords, i.e., 5 × 103 (Fig. 2). This
value for acutely infected spinal cords is in close accord with the
particle-to-PFU ratio of 3.19 × 103 for
BeAn virus infection of BHK-21 cells (16; also Table 2). The disparity between the viral genome load and infectious virus during
persistence in vivo remains unexplained but probably reflects the
neutralization of infectious virus by virus-specific antibodies and
CD4+ T cells (CD8+ T cells
do not appear to limit TMEV replication during persistent infection in
susceptible mouse strains; 11, 22), as well as the
restricted production of infectious virus by CNS macrophages, the
predominant cell type supporting TMEV replication (24,
30). The effect of immune responses on the viral RNA-to-PFU
ratio during persistence can be seen by using the DA virus-infected
C.B-17 cord virus titers provided by Njenga et al. (28) at
their latest time (day 13); in this case, ratios would be more on the
order of 103:1. Restriction of TMEV infection has
been reported in macrophages isolated from the mouse CNS
(10) and in infected murine macrophages in culture, where
a block in virus assembly rather than a block in viral RNA replication
most likely accounts for the low levels of infectious virus in the face
of substantial amounts of virus antigen (19, 39). The
block in infectious TMEV production in the macrophage cell line M1-D
contrasts with the productive infection in mature murine
oligodendrocytes seen in this study (Table 2).
BeAn viral RNA replication is not restricted or aberrant during
persistence.
Analysis of TMEV genome size in RNA extracted from
persistently infected spinal cords revealed only full-length species
(Fig. 3), indicating that subgenomic RNAs, such as those in
defective-interfering (DI) particles, are not produced during
persistent infection. This observation is consistent with the apparent
resistance against the production of DI particles of picornaviruses
compared to other RNA viruses, possibly due to a requirement for
cis-acting elements within the capsid coding region for RNA
replication (25-27). Furthermore, picornaviruses
generally require many serial passages in cells for DI formation
(reviewed in reference 7).
The ratios of TMEV RNA plus to minus strands were similar in cultures
of macrophages, oligodendrocytes, and BHK-21 cells (approximately 35:1;
Table 4) and consistent with the ratio reported for human poliovirus infection of HeLa cells (14, 29). The similar
ratio in CNS cells suggests that TMEV RNA replication is not restricted during persistent infection, although this does not exclude this possibility in a single cell type, e.g., macrophages or glial cells.
Cash et al. (5), using strand-specific probes and in situ
hybridization, also demonstrated that the plus- to minus-strand ratio
in spinal cord sections of DA virus-infected mice was similar to that
in infected BHK-21 cells. However, those authors concluded that
minus-strand synthesis was restricted, based in part on the low numbers
of TMEV copies detected. In that study, the majority of infected cells
in the spinal cord contained only 100 to 500 copies, with a small
percentage containing as many as 9,000 copies. Subsequently, these
methods were reported to have underestimated the number of TMEV RNA
copies in cells (4). By contrast, our data indicate
>105 viral RNA copies in oligodendrocytes and
macrophages in culture and >109 copies per
spinal cord. Although the number of infected cells is unknown, the
genome load in spinal cords of infected mice is difficult to explain
unless high numbers of TMEV RNA copies are present in most infected
cells. Together, these data suggest that TMEV RNA replication is not
restricted during the persistent phase of infection.
BeAn viral genome load in the spinal cord does not increase in an
immunodeficient host.
The heavy viral load in the spinal cords of
persistently infected SJL mice led us to expect even higher numbers of
viral genomes in C.B-17 scid mice, which lack humoral and
cellular immune clearance mechanisms and in which infectious titers are
high (28), and in CBA mice, in which crystalline arrays of
Theiler's virions indicative of productive infection have been
observed in oligodendrocytes during persistent infection
(2). Analysis of the viral load in these mouse strains
revealed viral genome levels in the spinal cord similar to those in SJL
mice. These results provide further evidence that viral RNA replication
is not restricted in the spinal cords of SJL mice. However, cells in
which TMEV replicates must differ in immunocompetent and
immunodeficient mice, since macrophages infiltrating the spinal cord
and serving as a major site of viral persistence in SJL mice are not
observed in TMEV-infected C.B-17 scid mice
(28). Interestingly, the viral load in the brains of
C.B-17 scid mice was extraordinarily heavy, with viral RNA copies representing 0.3% of the total brain mRNA, in contrast to the
undetectable viral genome levels in the brains of SJL mice, illustrating the effect of the immune system on BeAn virus replication in the brain.
BeAn virus persistence involves active viral RNA replication.
The infectivity plot in Fig. 2, indicating a logarithmic decline in
infectious virus after the acute growth phase and a slow decline
thereafter, suggests a restricted infection. By contrast, the temporal
curve showing viral RNA copies indicated active and probably continuous
viral RNA replication in TMEV persistence. In the transition from the
acute (approximately p.i. day 7) to the persistent (beginning on p.i.
day 28) phase of infection, viral RNA copy numbers steadily increased.
This is the time frame in which the site of infection in the spinal
cord shifts from gray to white matter, and macrophage infiltration (and
demyelination) is first observed in white matter. The mechanism(s)
underlying the shift in sites of infection are still unknown but may
hinge on the developing virus-specific immune responses that limit
viral spread during this time and on exclusive infiltration of white matter by macrophages. These data suggest that the rise in the number
of viral RNA copies is due principally to replication in macrophages;
however, further analysis of the temporal kinetics of viral RNA
replication between p.i. days 7 and 28 is needed, including more time
points and immunohistochemical analysis to relate these data to the
extent of macrophage infiltration.
The scheme we used to isolate the two principal target cell
populations, macrophages and oligodendrocytes, and determine the viral
genome load more reliably than by immunohistochemistry and in situ
hybridization was hampered by significant cell losses in cell recovery
from gradients, including trapping of both cells and viral RNA from
lysed cells in myelin debris. While infection of oligodendrocytes
accounted for approximately 20% of the viral genome load in the
gradients and a similar percentage by infection of macrophages, the
rest of the viral genome load could not be assigned. Nonetheless, our
isolation techniques do allow recovery of relatively pure populations
of macrophages and oligodendrocytes and will enable further examination
of TMEV infection in these cells taken directly from the spinal cord.
 |
ACKNOWLEDGMENTS |
We thank Matt Felrice and Brian Schlitt for technical assistance
and Mary Lou Jelachich for helpful discussions.
This work was supported by NIH grant NS 37732 and The Leiper Trust.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Neurology, Multiple Sclerosis Research Center, Evanston Hospital,
Northwestern University, 2650 Ridge Ave., Evanston, IL 60201-1782. Phone: (847) 570-2168. Fax: (847) 570-1568. E-mail:
hllipton{at}merle.acns.nwu.edu.
 |
REFERENCES |
| 1.
|
Aubert, C.,
M. Chamorro, and M. Brahic.
1987.
Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease.
Microb. Pathog.
3:319-326[CrossRef][Medline].
|
| 2.
|
Blakemore, W. F.,
C. J. Welsh,
P. Tonks, and A. A. Nash.
1988.
Observations on demyelinating lesions induced by Theiler's virus in CBA mice.
Acta Neuropathol.
76:581-589[CrossRef][Medline].
|
| 3.
|
Bureau, J.-F.,
X. Montagutelli,
S. Lefebvre,
J. L. Guenet,
M. Pla, and M. Brahic.
1992.
The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.
J. Virol.
66:4698-4704[Abstract/Free Full Text].
|
| 4.
|
Cash, E., and M. Brahic.
1986.
Quantitative in situ hybridization using initial velocity measurements.
Anal. Biochem.
157:266-270.
|
| 5.
|
Cash, E.,
M. Chamorro, and M. Brahic.
1988.
Minus-strand RNA synthesis in the spinal cords of mice persistently infected with Theiler's virus.
J. Virol.
62:1824-1826[Abstract/Free Full Text].
|
| 6.
|
Chamorro, M.,
C. Aubert, and M. Brahic.
1986.
Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection.
J. Virol.
57:992-997[Abstract/Free Full Text].
|
| 7.
|
Charpentier, N.,
M. Davila,
E. Domingo, and C. Escarmis.
1996.
Long-term, large-population passage of aphthovirus can generate and amplify defective noninterfering particles deleted in the leader protease gene.
Virology
223:10-18[CrossRef][Medline].
|
| 8.
|
Chen, B., and A. E. Przybala.
1994.
An efficient site-directed mutagenesis method based on PCR.
BioTechniques
17:657-659[Medline].
|
| 9.
|
Clatch, R. J.,
H. L. Lipton, and S. D. Miller.
1986.
Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
J. Immunol.
136:920-926[Abstract].
|
| 10.
|
Clatch, R. J.,
S. D. Miller,
R. Metzner,
M. C. Dal Canto, and H. L. Lipton.
1990.
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV).
Virology
176:244-254[CrossRef][Medline].
|
| 11.
|
Dethlefs, S.,
M. Brahic, and E.-L. Larsson-Sciard.
1997.
An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence.
J. Virol.
71:8875-8878[Abstract].
|
| 12.
|
Foster, L. M.,
T. Phan,
A. N. Verity,
D. Bredesen, and A. T. Campagnoni.
1993.
Generation and analysis of normal and shiverer temperature-sensitive immortalized cell lines exhibiting phenotypic characteristics of oligodendrocytes at several stages of differentiation.
Dev. Neurosci.
15:100-119[Medline].
|
| 13.
|
Gerety, S. J.,
K. M. Rundell,
M. C. Dal Canto, and S. D. Miller.
1994.
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
J. Immunol.
152:919-929[Abstract].
|
| 14.
|
Giachetti, C., and B. L. Semler.
1991.
Role of a viral membrane polypeptide in strand-specific initiation of poliovirus RNA synthesis.
J. Virol.
65:2647-2654[Abstract/Free Full Text].
|
| 15.
|
Haaft, P. T.,
B. Verstrepen,
K. Uberla,
B. Rosenwirth, and J. Heeney.
1998.
A pathogenic threshold of virus load in simian immunodeficiency virus- and simian-human immunodeficiency virus-infected macaques.
J. Virol.
72:10281-10285[Abstract/Free Full Text].
|
| 16.
|
Hertzler, S.,
M. Luo, and H. L. Lipton.
2000.
Mutation of predicted virion pit residues alters binding of Theiler's murine encephalomyelitis virus to BHK-21 cells.
J. Virol.
74:1994-2004[Abstract/Free Full Text].
|
| 17.
|
Hirsch, V. M.,
T. R. Fuerest,
G. Sutter,
M. W. Carroll,
L. C. Yang,
S. Goldstein,
M. Piatek, Jr.,
W. R. Elkins,
D. C. Montefiori,
B. Moss, and J. D. Lifson.
1996.
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.
J. Virol.
70:3741-3752[Abstract].
|
| 18.
|
Ho, D. D.,
A. U. Neumann,
A. S. Perelson,
W. Chen,
J. M. Leonard, and M. Markowitz.
1995.
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
Nature
373:123-126[CrossRef][Medline].
|
| 19.
|
Jelachich, M. L.,
P. Bandyopadhyay,
K. Blum, and H. L. Lipton.
1995.
Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation.
Virology
209:437-444[CrossRef][Medline].
|
| 20.
|
Jelachich, M. L.,
C. Brumlage, and H. L. Lipton.
1999.
Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis.
J. Virol.
73:3227-3235[Abstract/Free Full Text].
|
| 21.
|
Larsson-Sciard, E. L.,
S. Dethlefs, and M. Brahic.
1997.
In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence.
J Virol
71:797-799[Abstract].
|
| 22.
|
Lin, X.,
L. R. Pease,
P. D. Murray, and M. Rodriguez.
1998.
Theiler's virus infection of genetically susceptible mice induces central nervous system-infiltrating CTLs with no apparent viral or major myelin antigenic specificity.
J. Immunol.
160:5661-5668[Abstract/Free Full Text].
|
| 23.
|
Lipton, H. L., and R. Melvold.
1984.
Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice.
J. Immunol.
132:1821-1825[Abstract].
|
| 24.
|
Lipton, H. L.,
G. Twaddle, and M. L. Jelachich.
1995.
The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease.
J. Virol.
69:2525-2533[Abstract].
|
| 25.
|
Lobert, P.-E.,
N. Escriou,
J. Ruelle, and T. Michiels.
1999.
A coding RNA sequence acts as a replication signal in cardioviruses.
Proc. Natl. Acad. Sci. USA
96:11560-11565[Abstract/Free Full Text].
|
| 26.
|
McKnight, K. L., and S. M. Lemon.
1996.
Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA.
J. Virol.
70:1941-1952[Abstract].
|
| 27.
|
McKnight, K. L., and S. M. Lemon.
1998.
The rhinovirus type 14 genome contains an internally located RNA structure that is required for viral replication.
RNA
4:1569-1584[Abstract].
|
| 28.
|
Njenga, M. K.,
K. Asakura,
S. F. Hunter,
P. Wettstein,
L. R. Pease, and M. Rodriguez.
1997.
The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system.
J. Virol.
71:8592-8601[Abstract].
|
| 29.
|
Novak, J. E., and K. Kirkegaard.
1991.
Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells.
J. Virol.
65:3384-3387[Abstract/Free Full Text].
|
| 30.
|
Pena Rossi, C.,
M. Delcroix,
I. Huitinga,
A. McAllister,
N. van Rooijen,
E. Claassen, and M. Brahic.
1997.
Role of macrophages during Theiler's virus infection.
J. Virol.
71:3336-3340[Abstract].
|
| 31.
|
Pevear, D. C.,
M. Calenoff,
E. Rozhon, and H. L. Lipton.
1987.
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses.
J. Virol.
61:1507-1516[Abstract/Free Full Text].
|
| 32.
|
Piatek, M., Jr.,
M. S. Saag,
L. C. Yang,
S. J. Clark,
J. C. Kappes,
K.-C. Luk,
B. H. Hahn,
G. M. Shaw, and J. D. Lifson.
1993.
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
Science
259:1749-1754.
|
| 33.
|
Pope, J. G.,
W. J. Karpus,
C. VanderLugt, and S. D. Miller.
1996.
Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease.
J. Immunol.
156:4050-4058[Abstract].
|
| 34.
|
Pope, J. G.,
C. L. Vanderlugt,
S. M. Rahbe,
H. L. Lipton, and S. D. Miller.
1998.
Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus.
J. Virol.
72:7762-7771[Abstract/Free Full Text].
|
| 35.
|
Radany, E. H.,
M. Brenner,
F. Besnard,
V. Bigornia,
J. M. Bishop, and C. F. Deschepper.
1992.
Directed establishment of rat brain cell lines with the phenotypic characteristics of type 1 astrocytes.
Proc. Natl. Acad. Sci. USA
89:6467-6471[Abstract/Free Full Text].
|
| 36.
|
Rodriguez, M.,
J. L. Leibowitz, and P. W. Lampert.
1983.
Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis.
Ann. Neurol.
13:426-433[CrossRef][Medline].
|
| 37.
|
Rozhon, E. J.,
J. D. Kratochvil, and H. L. Lipton.
1983.
Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system.
Virology
128:16-32[CrossRef][Medline].
|
| 38.
|
Ruster, B.,
S. Zeuzem, and W. K. Roth.
1995.
Quantification of hepatitis C virus RNA by competitive reverse transcription and polymerase chain reaction using a modified hepatitis C virus transcript.
Anal. Biochem.
224:597-600[CrossRef][Medline].
|
| 39.
|
Shaw-Jackson, C., and T. Michiels.
1997.
Infection of macrophages by Theiler's murine encephalomyelitis virus is highly dependent on their activation or differentiation state.
J. Virol.
71:8864-8867[Abstract].
|
| 40.
|
Szuchet, S.,
B. G. W. Arnason, and P. Polak.
1980.
Separation of ovine oligodendrocytes into two distinct bands on a linear sucrose gradient.
J. Neurosci. Methods
3:7-19[CrossRef][Medline].
|
| 41.
|
Watson, A.,
J. Ranchais,
B. Travis,
J. McClure,
W. Sutton,
P. R. Johnson,
S.-L. Hu, and N. L. Haigwood.
1997.
Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.
J. Virol.
71:284-290[Abstract].
|
| 42.
|
Wei, X.,
S. K. Ghosh,
M. E. Taylor,
V. A. Johnson,
E. A. Emini,
P. Deutsch,
J. D. Lifson,
S. Ronhoeffer,
M. A. Nowak,
B. H. Hahn,
M. S. Saag, and G. M. Shaw.
1995.
Viral dynamics in human immunodeficiency virus type 1 infection.
Nature
373:117-122[CrossRef][Medline].
|
| 43.
|
Zeuzem, S.,
J. M. Schmidt,
J.-H. Lee,
B. Ruster, and W. K. Roth.
1996.
Effect of interferon alpha on the dynamics of hepatitis C virus turnover in vivo.
Hepatology
23:366-371[Medline].
|
Journal of Virology, August 2001, p. 7420-7428, Vol. 75, No. 16
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.16.7420-7428.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rodriguez, M., Zoecklein, L., Kerkvliet, J. G., Pavelko, K. D., Papke, L., Howe, C. L., Pease, L. R., David, C.
(2008). Human HLA-DR Transgenes Protect Mice from Fatal Virus-Induced Encephalomyelitis and Chronic Demyelination. J. Virol.
82: 3369-3380
[Abstract]
[Full Text]
-
Libbey, J. E., Tsunoda, I., Whitton, J. L., Fujinami, R. S.
(2007). Infectious RNA Isolated from the Spinal Cords of Mice Chronically Infected with Theiler's Murine Encephalomyelitis Virus. J. Virol.
81: 3009-3011
[Abstract]
[Full Text]
-
Ercolini, A. M., Miller, S. D.
(2006). Mechanisms of Immunopathology in Murine Models of Central Nervous System Demyelinating Disease. J. Immunol.
176: 3293-3298
[Abstract]
[Full Text]
-
Ure, D. R., Lane, T. E., Liu, M. T., Rodriguez, M.
(2005). Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection. Int Immunol
17: 569-579
[Abstract]
[Full Text]
-
Denton, P. W, Tello, C. M, Melvold, R. W
(2004). CD8 + T cells reduce in vitro interferon-g production in Theiler's murine encephalomyelitis virus-induced demyelinating disease model. Mult Scler
10: 370-375
[Abstract]
-
Rodriguez, M., Zoecklein, L. J., Howe, C. L., Pavelko, K. D., Gamez, J. D., Nakane, S., Papke, L. M.
(2003). Gamma Interferon Is Critical for Neuronal Viral Clearance and Protection in a Susceptible Mouse Strain following Early Intracranial Theiler's Murine Encephalomyelitis Virus Infection. J. Virol.
77: 12252-12265
[Abstract]
[Full Text]
-
Schlitt, B. P., Felrice, M., Jelachich, M. L., Lipton, H. L.
(2003). Apoptotic Cells, Including Macrophages, Are Prominent in Theiler's Virus-Induced Inflammatory, Demyelinating Lesions. J. Virol.
77: 4383-4388
[Abstract]
[Full Text]
-
Howard, L. M., Neville, K. L., Haynes, L. M., Dal Canto, M. C., Miller, S. D.
(2003). CD154 Blockade Results in Transient Reduction in Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease. J. Virol.
77: 2247-2250
[Abstract]
[Full Text]
-
Martinat, C., Mena, I., Brahic, M.
(2002). Theiler's Virus Infection of Primary Cultures of Bone Marrow-Derived Monocytes/Macrophages. J. Virol.
76: 12823-12833
[Abstract]
[Full Text]
-
Massa, P. T., Ropka, S. L., Saha, S., Fecenko, K. L., Beuler, K. L.
(2002). Critical Role for Protein Tyrosine Phosphatase SHP-1 in Controlling Infection of Central Nervous System Glia and Demyelination by Theiler's Murine Encephalomyelitis Virus. J. Virol.
76: 8335-8346
[Abstract]
[Full Text]
-
Aubagnac, S., Brahic, M., Bureau, J.-F.
(2002). Bone Marrow Chimeras Reveal Non-H-2 Hematopoietic Control of Susceptibility to Theiler's Virus Persistent Infection. J. Virol.
76: 5807-5812
[Abstract]
[Full Text]
-
Girard, S., Gosselin, A.-S., Pelletier, I., Colbere-Garapin, F., Couderc, T., Blondel, B.
(2002). Restriction of poliovirus RNA replication in persistently infected nerve cells. J. Gen. Virol.
83: 1087-1093
[Abstract]
[Full Text]
-
Girvin, A. M., Gordon, K. B., Welsh, C. J., Clipstone, N. A., Miller, S. D.
(2002). Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood
99: 3692-3701
[Abstract]
[Full Text]